R&D Service-南京科默生物医药有限公司

CN / EN

R&D Service

"one-stop" service platform covering from drug discovery to commercialization.

New Drug Preclinical Research Service

CMC Service

Clinical Research Service

New Drug Preclinical Research Service

Caremo empowers pharmaceutical companies to identify high-value drug candidates for clinical trials by delivering high-quality data and accelerated timelines. The preclinical research division of Caremo encompasses: Target screening and preclinical candidate compound (PCC) identification, Pharmacology and efficacy studies, Pharmacokinetics (PK) analysis, Preliminary toxicology and safety assessments.

Drug Discovery

Cell Biology

Pharmacokinetics

Pharmacodynamics

Drug Safety Evaluation

CMC Service

Caremo is dedicated to delivering high-quality, efficient, and integrated one-stop CMC (Chemical, Manufacturing, and Controls) services. Our offerings include: CMC Development for Generic Drugs & Small Molecule Innovative Drugs, Feasibility Assessment and Project Initiation, API & Formulation Process Optimization and Development, Pilot-Scale and Commercial-Scale Production, Stability Studies, Clinical Sample Manufacturing (GMP Compliance).

API

Pharmaceutical Preparations

Chemical Analysis

CDMO

NDA/ANDA Application

Clinical Research Service

Caremo provides one-stop clinical research services for domestic and international pharmaceutical companies, biotech firms, and medical device enterprises, spanning from preclinical evaluation (Pre-IND application) to post-marketing studies.

Regulatory Affairs

Medical affairs

Clinical trials

PMO project management

Subject recruitment

PCR平台④

这里是占位文字